Glutamatergic Modulation of Brain Function in Psychosis: A Systematic Review of Neuroimaging Studies.

Biol Psychiatry Cogn Neurosci Neuroimaging · 2025 · PMC7619035 · PMID 40701342

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Consistent with these findings, luvadaxistat at 50 mg showed a trend toward increased gamma power during ASSR in patients with schizophrenia, although this did not reach conventional significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.